Australian Writer Describes Antidepressant Withdrawal While Discussing U.S. Health Secretary's Proposal
A freelance writer detailed personal withdrawal symptoms after stopping venlafaxine. The account references U.S. Health Secretary Robert F. Kennedy Jr.'s announced campaign to reduce psychiatric drug use.
A freelance writer described severe withdrawal symptoms after attempting to stop venlafaxine, an antidepressant taken for more than a decade. The writer reported daily brain zaps, crying fits, nausea, anxiety and sudden episodes of despair during the second attempt to taper the medication in Australia.
The first attempt, conducted without regular medical access while living in the United States, produced confusion severe enough to mimic stroke symptoms. Five million Australians currently receive mental health-related prescriptions, according to the account.
U.S. Health Secretary's Proposal U.S. Health Secretary Robert F.
Kennedy Jr. announced a campaign to reduce reliance on psychiatric drugs. Measures include forming a technical expert panel to develop clinical guidelines for de-prescribing. The writer stated agreement with the emphasis on regulating these medications and treating them as temporary interventions.
American Psychiatric Association president Theresa Miskimen Rivera told National Public Radio that the approach oversimplifies access problems, noting many patients cannot obtain timely comprehensive care. The writer linked rising antidepressant use to limited availability of talk therapy and broader economic pressures including housing costs and social media effects. S.
tariff policy targeting Australia's Pharmaceutical Benefits Scheme and lobbying by pharmaceutical companies.
Key Facts
Story Timeline
3 events- Recent months
Writer began second attempt to stop venlafaxine after returning to Australia.
1 sourceThe Sydney Morning Herald - Undated
U.S. Health Secretary Robert F. Kennedy Jr. announced campaign to reduce psychiatric drug use.
1 sourceThe Sydney Morning Herald - Undated
American Psychiatric Association president Theresa Miskimen Rivera commented on the proposal to National Public Radio.
1 sourceThe Sydney Morning Herald
Potential Impact
- 01
Formation of an expert panel could produce new clinical guidelines for stopping psychiatric medications.
- 02
Increased regulatory scrutiny may affect how antidepressants are prescribed in the United States.
Transparency Panel
Related Stories
France 24Zambia’s Kabwe Residents Sue Mining Company Over Lead Contamination
Children in Kabwe, Zambia, show blood lead levels above World Health Organization limits after decades of mining. An estimated 140,000 women and children have joined a class-action lawsuit against Anglo American South Africa Limited.
citizen.co.zaEbola Outbreak in Eastern DRC Kills at Least 240 Since Early May
The virus has spread from Ituri province into other eastern DRC regions and Uganda. Health workers report reduced international aid and limited local resources as they attempt to contain transmission.
manilatimes.netOutbreaks of hantavirus and Ebola prompt U.S. quarantine and travel measures
The U.S. government ordered quarantines after a hantavirus outbreak on a cruise ship and imposed new traveler restrictions during an Ebola outbreak in Africa. Federal agencies stated that response operations continue despite recent staffing reductions at health agencies.